BridgeMD
New treatment option for HIV Infections
Official title South Africa Smoking Cessation and Engagement in HIV/TB Care Care
ClinicalTrials.gov ID: NCT05842161
What this study is testing
- What it's testing
- The purpose of this study is to integrate elements from existing interventions developed by our team into a single intervention (QUIT-AD), designed to improve smoking cessation and favorable HIV/TB treatment outcomes among individuals with HIV and/or TB in Cape Town, South Africa. If feasibility, acceptability, and preliminary efficacy are demonstrated, the intervention will be ready for large-scale effectiveness/implementation testing.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Aged 18 or older
- Willing and able to provide written informed consent
- Living with HIV, confirmed via medical record, and on antiretroviral therapy (ART) AND/OR within 1 month of initiating or reinitiating TB treatment...
You likely can't join if
- Habitual use of other tobacco products
- Current interfering untreated/unstable mental health condition (e.g., psychosis, bipolar dx)
- Current use of non-study pharmacotherapy for smoking cessation,
- Cognitive Behavioral Therapy for smoking cessation initiated within the past year,
- Diagnosed with extra-pulmonary or drug resistant (MDR or XDR) TB based upon chart review
The study team makes the final eligibility decision.
Where it's taking place
- Rondebosch, South Africa
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rondebosch, South Africa. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.